Sotera Health Company (SHC)

USD 13.2

(0.92%)

Net Income Summary of Sotera Health Company

  • Sotera Health Company's latest annual net income in 2023 was 51.37 Million USD , up 122.0% from previous year.
  • Sotera Health Company's latest quarterly net income in 2024 Q2 was 8.75 Million USD , up 38.45% from previous quarter.
  • Sotera Health Company reported an annual net income of -233.57 Million USD in 2022, down -299.83% from previous year.
  • Sotera Health Company reported an annual net income of 116.88 Million USD in 2021, up 411.76% from previous year.
  • Sotera Health Company reported a quarterly net income of 16.99 Million USD for 2024 Q3, up 94.06% from previous quarter.
  • Sotera Health Company reported a quarterly net income of 6.32 Million USD for 2024 Q1, down -83.65% from previous quarter.

Annual Net Income Chart of Sotera Health Company (2023 - 2018)

Historical Annual Net Income of Sotera Health Company (2023 - 2018)

Year Net Income Net Income Growth
2023 51.37 Million USD 122.0%
2022 -233.57 Million USD -299.83%
2021 116.88 Million USD 411.76%
2020 -37.49 Million USD -83.55%
2019 -20.42 Million USD -247.96%
2018 -5.87 Million USD 0.0%

Peer Net Income Comparison of Sotera Health Company

Name Net Income Net Income Difference
Bionano Genomics, Inc. -232.49 Million USD 122.098%
Prenetics Global Limited -62.72 Million USD 181.908%
Star Equity Holdings, Inc. -1.54 Million USD 3418.863%
CareDx, Inc -190.28 Million USD 127.0%
Exact Sciences Corporation -204.14 Million USD 125.166%
Exagen Inc. -23.68 Million USD 316.877%
Inotiv, Inc. -105.14 Million USD 148.864%
Guardant Health, Inc. -479.44 Million USD 110.716%
Biodesix, Inc. -52.14 Million USD 198.523%
BioNexus Gene Lab Corp. -2.62 Million USD 2054.171%
Precipio, Inc. -5.85 Million USD 977.772%
iSpecimen Inc. -11.09 Million USD 562.868%
Natera, Inc. -434.8 Million USD 111.816%
Aspira Women's Health Inc. -16.69 Million USD 407.825%
Standard BioTools Inc. -74.65 Million USD 168.817%
23andMe Holding Co. -666.7 Million USD 107.706%
Castle Biosciences, Inc. -57.46 Million USD 189.402%
Personalis, Inc. -108.29 Million USD 147.44%
Aclaris Therapeutics, Inc. -88.48 Million USD 158.064%
Applied DNA Sciences, Inc. -9.94 Million USD 616.494%
OpGen, Inc. -32.66 Million USD 257.264%
T2 Biosystems, Inc. -50.07 Million USD 202.594%
Myriad Genetics, Inc. -112 Million USD 145.871%
ICON Public Limited Company 612.33 Million USD 91.61%
NeoGenomics, Inc. -87.96 Million USD 158.403%
Star Equity Holdings, Inc. -1.54 Million USD 3418.863%
IDEXX Laboratories, Inc. 845.04 Million USD 93.92%
RadNet, Inc. 3.04 Million USD -1587.779%
MDxHealth SA -43.1 Million USD 219.202%
Psychemedics Corporation -4.15 Million USD 1336.784%
Illumina, Inc. -1.16 Billion USD 104.425%
Check-Cap Ltd. -17.56 Million USD 392.441%
Twist Bioscience Corporation -208.72 Million USD 124.614%
DarioHealth Corp. -59.42 Million USD 186.452%
Fulgent Genetics, Inc. -167.82 Million USD 130.613%
Sera Prognostics, Inc. -36.24 Million USD 241.758%
ENDRA Life Sciences Inc. -10.06 Million USD 610.683%
OPKO Health, Inc. -188.86 Million USD 127.203%
Medpace Holdings, Inc. 282.81 Million USD 81.834%
Neogen Corporation -9.42 Million USD 645.335%
Intelligent Bio Solutions Inc. -10.15 Million USD 605.831%
Prenetics Global Limited -62.72 Million USD 181.908%
Mainz Biomed B.V. -26.29 Million USD 295.378%
bioAffinity Technologies, Inc. -7.93 Million USD 747.297%
Trinity Biotech plc -24.01 Million USD 313.906%
Neuronetics, Inc. -30.18 Million USD 270.181%
bioAffinity Technologies, Inc. -7.93 Million USD 747.297%